Company / Shareholders' Equity
Voyager Therapeutics, Inc. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$299.8M
FY2025
5-year range
$59.0M / $299.8M
FY2021-FY2025
Trend
+407.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity changed +408% YoY in FY2025, a notable deviation from the 9-year average annual change of +147%.
Based on SEC 10-K filings.
$300M in FY2025 with a 5-year CAGR of +45.2%.
Improved from $95M to $300M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +24.8%
- 5-Year CAGR
- +45.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +45.2%, indicating consistent growth.
- In FY2025, shareholders' equity increased 407.9% year-over-year.
- Lowest shareholders' equity in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.34 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $299.8M | +407.9% |
| FY2024 | $59.0M | -37.9% |
| FY2023 | $95.1M | -38.4% |
| FY2022 | $154.3M | +55.1% |
| FY2021 | $99.5M | +114.3% |
| FY2020 | $46.4M | -65.4% |
| FY2019 | $134.1M | -1.4% |
| FY2018 | $135.9M | -19.6% |
| FY2017 | $169.1M | +911.7% |
| FY2016 | -$20.8M | -443.4% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026